An Overview: Preparation Characterization and Applications of Nanoparticles
For the past few decades, there has been a major investigate intrigues among the zone of medicate conveyance utilizing particulate conveyance frame works as carriers for the limited and expansive particles. Particulate frameworks like nanoparticles are utilizing as a physical approach to alter and move forward the pharmacological medicine and pharmacodynamics properties of various forms of sedate atoms. Nanoparticles area unit characterized as a particles with a breadth littler than 100nm, area unit increasingly utilize in many applications, count medicate framework and to pass organ obstructions like the blood brain barrier. Nano crystals and alternative nanoparticles are obtaining a parcel of thought for potential utilize in medicine, and medicine sedate revelation. The use of engineering science and prescription drugs and additional significantly sedate connivance is ready to unfold quickly. Right away various substances area unit at a lower place examination for sedate provides.
Keywords: Nanoparticles, Types, Method of Preparation, Evaluation, Applications.
2. Khosla G, Goswami L, Kothiyal P, Mukhopadhyay S. Nanoparticles: A Novelistic Approach for CNS disorders. Journal of Advanced Pharmaceutical Sciences 2012; 2:2: 220-259.
3. Abhilash M: Potential applications of Nanoparticles. International Journal of Pharma and Bio Sciences 2010; 1:1: 112.
4. Mullaicharam A.R: Nanoparticles in drug delivery system. International Journal of Nutrition, Pharmacology Neurological Diseases 2011; 1:2: 103-121.
5. Vyas SP, Khar RK. Targeted and controlled drug delivery. CBS publishers and distributers. New Delhi ocfx 2002; 1:331–43.
6. Pangi Z, Beletsi A. Even gelatos K. PEG-ylated nanoparticles for biological and pharmaceutical application. Adv drug Del rev. 2003; 24: 403-19.
7. Anilkumar J Shinde, and Harinath N. Nanoparticles - As Carriers for Drug Delivery System. 2009; 3(4): 80-86.
8. https://www.azonano.com/article.aspx?ArticleID=4938#:~:targetText=Nanoparticles%20can%20be%20 classified%20into,nanoparticles%20and%20lipid%2Dbased%20nanoparticles.
9. Nikam Arti P., Mukesh Ratnaparkhiand P., Chaudhary Shilpa P: Nanoparticles-an overview, Int. J. Res.Dev. Pharm. L. Sci. 2014; 3(5): 1121-1127.
10. Kaparissides C, Alexandridou S, Kotti K, Chaitidou S: Recent advances in novel drug delivery systems 2006; 2026-2027.
11. Kohler Fritzsche W: Nanotechnology. An introduction to Nanostructuring Koosha F, Muller RH, Davis SS, Davies MC. The surface chemical structure of poly (-hydroxybutyrate) microparticles produced by solvent evaporation process. J Control Release 1989; 9:149-57.
12. Desgouilles St, Vauthier C, Bazile D, Joe¨l Vacus, Grossiord Jean-Louis, Veillard Mi, and Patrick Couvreur: The Design of Nanoparticles Obtained by Solvent Evaporation. A Comprehensive Study Langmuir 2003; 19: 9504-9510.
13. Ueda M, Kreuter J. Optimization of the preparation of loperamide- loaded poly (l-lactide) nanoparticles by high pressure emulsification solvent evaporation. J Microencapsul. 1997; 14: 593–605.
14. Nagavarma, B.V.N, Hemant, K.S, Yadav, Ayaz, Vasudh, L.S, Shivakumar, H.G. Different techniques for preparation of polymeric nanoparticles- a review. Asian J. Pharm. Clin. Res. 2012; 5(3): 16-23.
15. Hu FQ ,Yuan H, Jiang SP, Du YZ, Ye YQ, Zeng S: Preparation and Characterisation of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surfaces B Biointerfaces 2005; 45(3): 167-173.
16. Lal pal S, Jana U, Manna P.K., Mohanta G.P., Manavalan R: Nanoparticles: An overview of preparation and characterization. Journal of Applied Pharmaceutical Science 2001; 01 (06):228-234.
17. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E: Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998; 24: 113-128.
18. Prathna T.C., Lazar Mathew N., Chandrasekaran, Ashok M. Raichur, Amitava Mukherjee: Biomimetic synthesis of nanoparticles: science, technology & applicability. In: Amitava Mukherjee (Ed.), Biomimetics, learning from nature. Published by InTechOpen 2010.
19. Iravani S, Zolfaghari B: Green synthesis of silver nanoparticles using Pinus eldarica bark extract. Hindawi Publishing Corporation, Biomed. Res. Int. 2013; 1-5.
20. Bilati U, Eric All emann, Eric Doelker. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. European Journal of Pharmaceutical Science 2005; 24(1):67–75.
21. Prasad Rao, J., Kurt Geckeler, E. Polymer nanoparticles: Preparation techniques and size-control parameters. Prog. Polymer Sc. 2011; 36(7): 887-913.
22. Gelation preparation technique Umasankar K, Uma Maheswara Reddy C. Formulation and Evaluation of Cytarabine Nanoparticles. International Journal of Innovative Pharmaceutical Research 2010; 1(2):48-52.
23. Katherine Bowman, Kam W Leong. Chitosan Nanoparticles for Oral drug and Gene Delivery. Int J of Nanomedicine 2006; 1(2): 117–128.
24. Sailaja et al. Different Techniques for the preparation of nanoparticles using natural polymers and their applications. Int J Pharm Sci. 2011; 3 (2): 45-50.
25. Renu T. A Review on nanoparticles–preparation and evaluation parameters. Indian Journal of Pharmaceutical and Biological Research (IJPBR) 2015; 4(2): 27-31.
26. Tripura SP. Et al. Formulation and Evaluation of Fabuxostat Nanoparticles. American Journal of Pharm Tech research 2014; 4(1): 2249-2287.
27. Yadav N, khatak S, Vir Singh U: Solid lipid nanoparticles- a review. International journal of applied pharmaceutics 2013; 5(2): 8-18.
28. Allemann E, Gurny R, Doekler E: Drug-loaded nanoparticle preparation methods and drug targeting issues. Eur J Pharm Biopharm. 1993; 39:173–91.
29. Lakshmana Prabu S, Shirwaikar AA, Shirwaikar A, Kumar A: Formulation and evaluation of sustained release microspheres of rosin containing Aceclofenac, Ars Pharm 2009; 50:2: 5162.
30. Das S, Banerjee R and Bellare J: Aspirin Loaded Albumin Nanoparticles by Coacervation: Implications in Drug Delivery, Trends Biomater. Artif Organs 2005; 18:2: 1-10.
31. Aejaz A, Azmail K, Sanaullah S and Mohsin A: Formulation and in vitro evaluation of Aceclofenac solid dispersion incorporated gels. International Journal of Applied Sciences 2010; 2:1: 7-12.
32. Tamizhrasi S, Shukla A, Shivkumar T, Rathi V, Rathi J. C: Formulation and evaluation of Lamivudine loaded polymethacrylic acid nanoparticles. International Journal of PharmTech Research [IJPRIF] 2009; 1:3: 411-415.
33. Mukhopadhyay S, Madhav Satheesh N.V. and Upadhyaya K: Formulation and evaluation of bionanoparticulated drug delivery of Rivastigmine. World Journal of Pharmaceutical Sciences 2016; 4:5: 264-272.
34. Redhead H M., Davis SS. and Illum L. J Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation Control. Release. 2001; 70: 353.
35. DeAssis DN., Mosqueira VC., Vilela JM., Andrade M.S., Cardoso VN: Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99m Technetium – fluconazole nanocapsules. Int J Pharm. 2008; 349: 152 – 160.
36. Jores K., Mehnert W., Drecusler M., Bunyes H., Johan C., MAder K: Investigation on the stricter of solid lipid nanopartuicles and oil-loaded solid nanoparticles by photon correlation spectroscopy, field- flow fractionasition and transmission electron microscopy. J Control Release. 2004; 17: 217- 227.
37. Molpeceres J., Aberturas MR., Guzman M: Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. J Microencapsul. 2000; 17: 599-614.
38. Dolenc A, Govedarica B, Dreu R, Kocbek P, Srčič S, Kristl J: Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. International Journal of Pharmaceutics. 2010; 396(1):149-55. 20
39. Choi, H.K., Jung, J.H., Ryu J.M., Yoon, S.J., Oh, Y.K. and Kim: Development of insitu gelling and mucoadhesive acetamoniphen liquid suppository, Int. J pharm. 1998;165 :3344.
40. Molpeceres J., Aberturas MR., Guzman M: Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. J Microencapsul. 2000; 17: 599-614.
41. Muhlen AZ., Muhlen EZ., Niehus H., Mehnert W: Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res. 13:14111416(1996).
42. Shi HG., Farber L., Michaels JN., Dickey A., Thompson KC., Shelukar SD., Hurter PN., Reynolds SD., Kaufman MJ: Characterization of crystalline drug nanoparticles using atomic force microscopy and complementary techniques. Pharm Res. 20: 479 – 484 (2003).
43. Polakovic M., Gorner T., Gref R., Dellacherie E: Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release. 1999; 60: 169 -177.
44. Pangi Z., Beletsi A., Evangelatos K. :PEG-ylated nanoparticles for biological and pharmaceutical application. Adv Drug Del Rev. 2003; 24: 403- 419.
45. Scholes PD., Coombes AG., Illum L., Davis SS., Wats JF., Ustariz C., Vert M., Davies MC: Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J control Release 1999; 59: 261 - 278.
46. Anil kumar J. Shinde and Harinath N: Formulation, development and characterization of Simvastatin nanoparticles by solvent displacement method, Der Pharmacia Lettre, 2014; 6:2: 145-155.
47. Jaiswal J., Gupta SK., Kreuter J: Preparation of biodegradable cyclosporine nanoparticles by high- pressure emulsification solvent evaporation process. J Control Release. 2004; 96:1692-1708.
48. Kreuter J: Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 1983; 14: 43 - 58.
49. Magenhein B., Levy MY., Benita S: A new in vitro technique for the evaluation of drug release profile from colloidal carriers ultrafiltration technique at low pressure. Int. J. Pharm. 1993; 94: 115-123.
50. Hoet PMH., Brnske HI., Salata OR: Nano particles known and unknown health risk. J nanobiotecnol. 2004; 2:12.
51. Lee KP., Kelly DP., Oneal FO., Kennedy GL: Lung response to ultrafine kertar aramid synthetic fibrils following 2-year inhalation exposure in rats. Findam Appl Toxicol. 1998;11:1-20
52. Mecke A., Uppuluri S., Sassanella TM., Lee DK., Ramamoorthy A., Baker Jr JR: Direct observation of lipid bilayer disruption by poly (amidoamine) dendrimers. Chem Phys Lipids. 2004; 132:3-14.
53. Yoo HS., Oh JE., Lee KH., Park TG: Biodegradable nanosparticles containing PLGA conjugates for sustained release. Pharm Res. 1999; 16: 1114-1118.
54. Jani P., Halbert GW., Langridge J., Florence AT: Nanoparticles uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol.1990; 42(12):812-826.
55. Jani P., Halbert GW., Langridge J., Florence AT: The uptake and translocation of latex nanosphere and microsphere after oral administration to rats. J Pharm Pharmacol.1989; 41(12) 809-812.
56. Lademann J., Weigmann H., Rickmeyer C., Barthelmes H., Schaelmes H., Mueller G, Sterry W: Penetration of Titanium Dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacology and Applied Skin Physiology1999; 12: 247- 256.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).